MPZ and hereditary sensory and autonomic neuropathy: Patients negative for mutations in PMP22, GJB1 and MPZ, and patients with atypical CMT2, HSAN and HMN should be subjected to extended analysis by NGS and prioritization of the genes to be investigated should be based on detailed studies of the phenotype.